Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Carlos Roncal to Chemokine CCL2

This is a "connection" page, showing publications Carlos Roncal has written about Chemokine CCL2.

 
Connection Strength
 
 
 
0.176
 
  1. Roncal C, Mu W, Reungjui S, Kim KM, Henderson GN, Ouyang X, Nakagawa T, Johnson RJ. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease. Am J Physiol Renal Physiol. 2007 Oct; 293(4):F1391-6.
    View in: PubMed
    Score: 0.071
  2. Roncal CA, Mu W, Croker B, Reungjui S, Ouyang X, Tabah-Fisch I, Johnson RJ, Ejaz AA. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F116-22.
    View in: PubMed
    Score: 0.068
  3. S?nchez-Lozada LG, Mu W, Roncal C, Sautin YY, Abdelmalek M, Reungjui S, Le M, Nakagawa T, Lan HY, Yu X, Johnson RJ. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur J Nutr. 2010 Feb; 49(1):1-9.
    View in: PubMed
    Score: 0.020
  4. Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, Sautin YY, Johnson RJ, Nakagawa T. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol. 2007 Oct; 293(4):F1256-61.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)